Portable multichannel ECG for patients with suspected CAD or symptoms of acute CAD
National Taiwan University Hospital
About the Team
Developing a multichannel electrocardiogram testing system that can quickly assess patients with suspected coronary disease or symptoms of acute coronary disease. This system will help reduce unnecessary extended stay in the emergency room and minimize wasted medical resources.
Completed multi-channel ECG testing system prototype, obtained TFDA certificate for human clinical trial, clinical validations are presently ongoing. On March 9,2020 formed MECG BIOTECHNOLOGY LTD.